Humana (NYSE:HUM) Stock Price Expected to Rise, Truist Financial Analyst Says

Humana (NYSE:HUM) had its price objective boosted by analysts at Truist Financial from $320.00 to $415.00 in a report issued on Tuesday,Benzinga reports. The brokerage presently has a “hold” rating on the insurance provider’s stock. Truist Financial’s price objective points to a potential upside of 1.34% from the stock’s current price.

Other equities analysts also recently issued reports about the company. Wolfe Research upgraded Humana from a “hold” rating to a “strong-buy” rating in a research report on Thursday, June 4th. TD Cowen upped their target price on Humana from $173.00 to $211.00 and gave the company a “hold” rating in a report on Friday, May 1st. Deutsche Bank Aktiengesellschaft downgraded shares of Humana from a “buy” rating to a “hold” rating in a research report on Wednesday, May 20th. Cantor Fitzgerald boosted their price target on shares of Humana from $264.00 to $300.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 7th. Finally, Evercore upped their price objective on shares of Humana from $250.00 to $370.00 in a research note on Thursday, June 11th. One research analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, sixteen have given a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $319.83.

Humana Stock Performance

NYSE HUM opened at $409.53 on Tuesday. The company has a market capitalization of $49.17 billion, a price-to-earnings ratio of 43.86, a PEG ratio of 2.24 and a beta of 0.71. The company has a quick ratio of 1.77, a current ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana has a twelve month low of $163.11 and a twelve month high of $415.00. The stock has a fifty day simple moving average of $342.18 and a 200 day simple moving average of $256.22.

Humana (NYSE:HUM) last announced its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 EPS for the quarter, topping the consensus estimate of $9.97 by $0.34. Humana had a return on equity of 10.45% and a net margin of 0.82%.The firm had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. During the same period in the previous year, the business earned $11.58 EPS. The business’s quarterly revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. Sell-side analysts expect that Humana will post 9.03 EPS for the current year.

Hedge Funds Weigh In On Humana

A number of institutional investors and hedge funds have recently modified their holdings of the business. Montag A & Associates Inc. increased its stake in shares of Humana by 1,880.0% in the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock valued at $25,000 after acquiring an additional 94 shares in the last quarter. CoreCap Advisors LLC boosted its stake in Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after acquiring an additional 37 shares in the last quarter. Fideuram Asset Management Ireland dac bought a new position in Humana during the fourth quarter worth $27,000. Reflection Asset Management acquired a new stake in Humana in the fourth quarter worth $29,000. Finally, Rosenberg Matthew Hamilton grew its holdings in Humana by 136.0% in the fourth quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock worth $30,000 after purchasing an additional 68 shares during the period. 92.38% of the stock is currently owned by institutional investors.

Humana Company Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.